Dermatology Times: June 2, 2025

12345678910111213141516
Across
  1. 4. Abbreviation for a persistent skin condition that affects the hands and lacks FDA-approved treatments
  2. 5. Aggressive skin cancer emphasized during May awareness campaigns and in early detection initiatives
  3. 7. Aesthetic pharmaceutical company supporting confidence-based care models
  4. 10. Minimally invasive technique shown to be more effective than injections for melasma PRP delivery
  5. 11. Biologic particles studied for regenerative potential in comparison to platelet-rich plasma
  6. 12. AI-powered device recently CE-marked in Europe for melanoma detection
  7. 14. Acronym for platelet-rich plasma, studied as a treatment for melasma and skin rejuvenation
  8. 16. Skin care specialist now accessible virtually through the Skin Clique’s teledermatology program
Down
  1. 1. Central theme in aesthetic dermatology driven by patient-empowerment and self-perception
  2. 2. Investigational biologic showing promise in phase 2b trials for atopic dermatitis
  3. 3. IL-31 receptor blocker noted for reducing itch in patients with atopic dermatitis
  4. 6. Monoclonal antibody discussed for its role in treating moderate to severe atopic dermatitis in ADvocate trials
  5. 8. Genetic blistering disorder targeted by novel topical delivery innovations
  6. 9. Autoimmune condition associated with variable mental health risks by race
  7. 13. (Abbreviation) Professional society spotlighted for supporting dermatology nurse practitioners through leadership and education
  8. 15. Advocacy group collaborating with Dermaliq on enhanced drug delivery systems for epidermolysis bullosa